These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5527013)

  • 1. Combination therapy with vincristine sulfate (NSC-67574) and cyclophosphamide (NSC-26271) for generalized malignant schwannoma--a case report.
    Valdes OS; Maurer HM
    Cancer Chemother Rep; 1970 Feb; 54(1):65-8. PubMed ID: 5527013
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.
    Goldman RL; Jones SE; Heusinkveld RS
    Cancer; 1977 May; 39(5):1955-8. PubMed ID: 858125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
    Tucker WG; Talley RW; Lane M; Bonnet JD
    Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug trials in neuroblastoma: cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus cyclophosphamide; 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone.
    Starling KA; Sutow WW; Donaldson MH; Land VJ; Lane DM
    Cancer Chemother Rep; 1974; 58(5 Pt 1):683-8. PubMed ID: 4426047
    [No Abstract]   [Full Text] [Related]  

  • 5. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
    Gasparini M; Bellani FF; Musumeci R; Bonadonna G
    Cancer Chemother Rep; 1974; 58(3):365-70. PubMed ID: 4601666
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040).
    Bitran J; Golomb HM; Desser RK; Colman M
    Cancer Treat Rep; 1976 Mar; 60(3):221-3. PubMed ID: 177208
    [No Abstract]   [Full Text] [Related]  

  • 7. Remission induction in childhood leukemia with second course vincristine (NSC-67574) and prednisone (NSC-10023) therapy.
    Cancer Chemother Rep; 1970 Apr; 54(2):113-8. PubMed ID: 4946001
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
    Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053).
    Senyszyn JJ; Johnson RE; Curran RE
    Cancer Chemother Rep; 1970 Apr; 54(2):103-7. PubMed ID: 4945999
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of small cell carcinoma of the lung using methyl-CCNU (NSC-95441) combined with cyclophosphamide (NSC-26271) and vincristine (NSC-67574) in a 3-week schedule.
    Taylor SG; Donavan MA; Sponzo RW; Cunningham TJ; Horton J
    Cancer Chemother Rep; 1975; 59(6):1127-30. PubMed ID: 769951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 12. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumors.
    Foley JF; Lemon HM; Miller D
    Cancer Chemother Rep; 1970 Feb; 54(1):41-6. PubMed ID: 4334084
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of dosage schedules of mitomycin C (NSC-26980) in children.
    Sutow WW; Wilbur JR; Vietti TJ; Vuthibhagdee P; Fujimoto T; Watanabe A
    Cancer Chemother Rep; 1971 Jun; 55(3):285-9. PubMed ID: 4107239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of malignant schwannoma with overexpression of multidrug resistance gene (MDR1) after chemotherapy.
    Suto R; Abe Y; Lee YH; Ueyama Y; Yamazaki H; Kijima H; Hiraoka N; Fukuda H; Tamaoki N; Nakamura M
    Anticancer Res; 1997; 17(3C):2273-7. PubMed ID: 9216701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vincristine sulfate and cyclophosphamide chemotherapy for metastatic neuroblastoma.
    Sullivan MP; Nora AH; Kulapongs P; Lane DM; Windmiller J; Thurman WG
    Pediatrics; 1969 Nov; 44(5):685-94. PubMed ID: 5374979
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.
    Ahmann DL; Bisel HF; Eagan RT; Edmonson JH; Hahn RG
    Cancer Chemother Rep; 1974; 58(6):877-82. PubMed ID: 4614896
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.
    Livingston RB; Bodey GP; Gottlieb JA; Frei E
    Cancer Chemother Rep; 1973 Apr; 57(2):219-24. PubMed ID: 4126382
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy and prognosis of neuroblastoma. Report of 54 cases observed in Switzerland].
    Taminelli F; Käser H; Wagner HP
    Helv Paediatr Acta; 1970 Dec; 25(6):554-65. PubMed ID: 5515939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.